Pixium Vision

Muqit (UK), Yannick Le Mer (F), Frank G. Holz (D) et al around the subretinal PRIMA microchip for geographic atrophy in age-related is now available on PubMed.

🔍 The study focused on long-term observations of macular thickness after the implantation. The results? This innovative implant not only provides a safe and effective alternative to more invasive procedures but also maintains its efficacy over a considerable period.

👁️ Unlike complex brain implants requiring skull incision with a cranial drill and bone flap removal, this minimally invasive technique specifically targets the back of the eye. It electrically stimulates the inner retinal neurons to restore partial vision. What's impressive is the stability of the implant-to-cell distance and the overall minimal changes in retinal thickness, which stabilizes just three months post-operation. The findings reveal that after the initial period following surgery, there's no significant adverse structural or functional impact, maintaining retinal thickness and health over 36 months. This is a significant reassurance for patients and practitioners alike, suggesting a promising future for those suffering from AMD.

💡 This research emphasizes the incredible potential of targeted, minimally invasive surgical techniques in treating complex conditions like AMD.

For more details, read the article here: https://pubmed.ncbi.nlm.nih.gov/36174540/